ストックスクリーナーアプリを入手
106.28
1.96%
-2.13
Sarepta Therapeutics Inc (SRPT) 最新ニュース
Sarepta Therapeutics (SRPT) Projected to Announce Quarterly Earnings on Wednesday - MarketBeat
Rhumbline Advisers Reduces Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
AlphaCentric Advisors LLC Lowers Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Is Sarepta Therapeutics, Inc. (SRPT) The Best Fast Growth Stock To Buy Right Now? - Insider Monkey
15 Best Fast Growth Stocks To Buy Right Now - Insider Monkey
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sarepta Therapeutics (NASDAQ:SRPT) Hits New 52-Week LowHere's Why - MarketBeat
Van ECK Associates Corp Raises Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here? - Benzinga
Sarepta Therapeutics Closes $600M in Senior Secured Revolving Credit Facility - citybiz
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Purchased by Peregrine Capital Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Acquires 84,926 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock - MSN
SRPT Quantitative Stock Analysis - Nasdaq
Solid says early data suggest ‘differentiated’ Duchenne gene therapy - BioPharma Dive
Sarepta stock touches 52-week low at $101.32 amid market challenges - Investing.com
Braun Stacey Associates Inc. Sells 2,990 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Sarepta Therapeutics (NASDAQ:SRPT) Receives Sell Rating from HC Wainwright - MarketBeat
Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround - MSN
Banque Pictet & Cie SA Has $5.35 Million Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Fiera Capital Corp Sells 9,667 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Arrowhead and Sarepta close $500 million licensing deal - MSN
Sarepta closes on $600M revolving credit facility - MSN
Sovran Advisors LLC Invests $3.21 Million in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Sarepta Therapeutics closes on $600M credit facility - TradingPedia
Sapient Capital LLC Cuts Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
WCM Investment Management LLC Buys 12,060 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Sarepta Therapeutics (NASDAQ:SRPT) Now Covered by Analysts at Deutsche Bank Aktiengesellschaft - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility - Marketscreener.com
Sarepta Therapeutics Closes $600 Million Revolving Credit Facility -February 14, 2025 at 09:08 am EST - Marketscreener.com
SRPTSarepta Therapeutics Inc Latest Stock News & Market Updates - StockTitan
Sarepta Q4 Earnings Preview: Rare Disease Leader's Full-Year Performance Revealed - StockTitan
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Gladstone Institutional Advisory LLC - MarketBeat
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results - Business Wire
Deutsche Bank sets Sarepta stock target at $136, cites risks - MSN
Deutsche Bank Initiates Coverage on Sarepta Therapeutics With Hold Rating, $136 Price Target - Marketscreener.com
Tobam Has $3.52 Million Holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - MarketBeat
Arrowhead Secures Massive $825M Deal as FDA Fast-Tracks Breakthrough Drug - StockTitan
Arrowhead Closes Licensing, Collaboration Agreement With Sarepta -February 10, 2025 at 09:39 am EST - Marketscreener.com
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics - BioSpace
Arrowhead to receives $500M upfront in licensing pact with Sarepta - TipRanks
ARWR Seals Mega-Deal: $825M Cash Infusion Plus Billions in Potential Milestone Payments - StockTitan
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):